These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27943045)

  • 1. The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.
    Levis B; Kwakkenbos L; Hudson M; Baron M; Thombs BD;
    Clin Rheumatol; 2017 Feb; 36(2):373-379. PubMed ID: 27943045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.
    Thombs BD; Hudson M; Bassel M; Taillefer SS; Baron M;
    Arthritis Rheum; 2009 Jul; 61(7):966-73. PubMed ID: 19565539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale.
    Harel D; Thombs BD; Hudson M; Baron M; Steele R;
    Rheumatology (Oxford); 2012 Dec; 51(12):2177-85. PubMed ID: 22923749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden and determinants of fatigue in incident and prevalent systemic sclerosis.
    Fairley JL; Hansen D; Proudman S; Baron M; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Stevens W; Ross L; Nikpour M
    Clin Exp Rheumatol; 2024 Aug; 42(8):1669-1674. PubMed ID: 39152749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of fatigue and its relationships with disease-related parameters in patients with systemic sclerosis.
    Ibn Yacoub Y; Amine B; Bensabbah R; Hajjaj-Hassouni N
    Clin Rheumatol; 2012 Apr; 31(4):655-60. PubMed ID: 22187224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
    Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
    Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.
    Hinchcliff M; Beaumont JL; Thavarajah K; Varga J; Chung A; Podlusky S; Carns M; Chang RW; Cella D
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1620-8. PubMed ID: 22034123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
    Schieir O; Thombs BD; Hudson M; Boivin JF; Steele R; Bernatsky S; Hanley J; Baron M;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):409-17. PubMed ID: 20391488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus.
    Milette K; Hudson M; Körner A; Baron M; Thombs BD;
    Rheumatology (Oxford); 2013 Sep; 52(9):1715-20. PubMed ID: 23804222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study.
    Racine M; Hudson M; Baron M; Nielson WR;
    J Pain Symptom Manage; 2016 Jul; 52(1):43-53. PubMed ID: 26876159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group.
    Mansour S; Bonner A; Muangchan C; Hudson M; Baron M; Pope JE;
    J Rheumatol; 2013 Apr; 40(4):447-54. PubMed ID: 23418377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study.
    Kwakkenbos L; Sanchez TA; Turner KA; Mouthon L; Carrier ME; Hudson M; van den Ende CHM; Schouffoer AA; Welling JJKC; Sauvé M; Thombs BD;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):88-94. PubMed ID: 30277865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.
    Kwakkenbos L; Willems LM; Baron M; Hudson M; Cella D; van den Ende CH; Thombs BD;
    PLoS One; 2014; 9(3):e91979. PubMed ID: 24638101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis.
    Lee SW; Kim BK; Park JY; Kim DY; Ahn SH; Song JJ; Park YB; Lee SK; Han KH; Kim SU
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S68-74. PubMed ID: 26243041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample.
    Leavens A; Patten SB; Hudson M; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1195-201. PubMed ID: 22438281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey.
    Bassel M; Hudson M; Taillefer SS; Schieir O; Baron M; Thombs BD
    Rheumatology (Oxford); 2011 Apr; 50(4):762-7. PubMed ID: 21149249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function in Italian women with systemic sclerosis is affected by disease-related and psychological concerns.
    Maddali Bongi S; Del Rosso A; Mikhaylova S; Baccini M; Matucci Cerinic M
    J Rheumatol; 2013 Oct; 40(10):1697-705. PubMed ID: 23996290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.